DOW JONES22,091.83+455.05 2.10%
S&P 5002,605.20+63.73 2.51%
NASDAQ7,707.81+205.43 2.74%

Albireo Pharma Q4 EPS $(0.57) Beats $(1.59) Estimate, Sales $6.431M Beat $1.54M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.59) by 64.15 percent. This is a 57.46 percent increase over losses of $(1.34) per share from

Benzinga · 03/02/2020 12:31

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.59) by 64.15 percent. This is a 57.46 percent increase over losses of $(1.34) per share from the same period last year. The company reported quarterly sales of $6.431 million which beat the analyst consensus estimate of $1.54 million by 317.60 percent. This is a 1.03K percent increase over sales of $571 thousand the same period last year.